Tu1735 TREATMENT OUTCOME OF TOFACITINIB DOSE REDUCTION TO 5 MG TWICE DAILY (BID) VS REMAINING ON 10 MG BID IN PATIENTS WITH ULCERATIVE COLITIS WHO WERE IN STABLE REMISSION ON 10 MG BID: UPDATED 30 MONTH DATA FROM THE DOUBLE-BLIND, RANDOMIZED RIVETING STUDY | Publicación